Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 3, Pages 474
Publisher
MDPI AG
Online
2022-02-23
DOI
10.3390/pharmaceutics14030474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanomedicine-enabled chemotherapy-based synergetic cancer treatments
- (2022) Wencheng Wu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy
- (2021) Jianhua Liu et al. MATERIALS & DESIGN
- Paradigms on Immunotherapy Combinations with Chemotherapy
- (2021) Diego Salas-Benito et al. Cancer Discovery
- Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
- (2021) Juan Gonzalez-Valdivieso et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia
- (2021) J. R. Rivas et al. LEUKEMIA
- Metabolic regulation of the cancer-immunity cycle
- (2021) Luis F. Somarribas Patterson et al. TRENDS IN IMMUNOLOGY
- Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
- (2020) Rachael M. Zemek et al. Frontiers in Immunology
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- Reverting Immune Suppression to Enhance Cancer Immunotherapy
- (2020) Bella S. Guerrouahen et al. Frontiers in Oncology
- Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
- (2020) Jing Gao et al. ACTA PHARMACOLOGICA SINICA
- The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
- (2020) Florent Petitprez et al. Frontiers in Immunology
- Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
- (2020) Yongwhan Choi et al. Pharmaceutics
- Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts
- (2019) Holly A. Maulhardt et al. Cancers
- Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer
- (2019) James W. Opzoomer et al. Frontiers in Immunology
- Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
- (2019) Oliver Kepp et al. OncoImmunology
- Recent Progress in the Development of Poly(lactic-co-glycolic acid)-Based Nanostructures for Cancer Imaging and Therapy
- (2019) Ki-Taek Kim et al. Pharmaceutics
- Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
- (2019) Alfonso Serrano-del Valle et al. Frontiers in Cell and Developmental Biology
- Quantitative Assessment of Nanoparticle Biodistribution by Fluorescence Imaging, Revisited
- (2018) Fanfei Meng et al. ACS Nano
- Customizing poly(lactic- co -glycolic acid) particles for biomedical applications
- (2018) Edyta Swider et al. Acta Biomaterialia
- Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
- (2018) Eric M. Mastria et al. JOURNAL OF CONTROLLED RELEASE
- New Avenues for Nanoparticle-Related Therapies
- (2018) Michael Zhao et al. Nanoscale Research Letters
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- New Avenues for Nanoparticle-Related Therapies
- (2018) Michael Zhao et al. Nanoscale Research Letters
- Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy
- (2018) Qin Fan et al. ADVANCED FUNCTIONAL MATERIALS
- Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters inflammation-resolution program in the myocardium
- (2018) Jeevan Kumar Jadapalli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- PLGA-Based Nanoparticles in Cancer Treatment
- (2018) Sima Rezvantalab et al. Frontiers in Pharmacology
- Nanomedicinal products: a survey on specific toxicity and side effects
- (2017) Walter Brand et al. International Journal of Nanomedicine
- Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy
- (2017) Sung Duk Jo et al. Nano Today
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
- (2016) Christina Giannakou et al. International Journal of Nanomedicine
- Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories
- (2016) Yihan Xu et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Bronchoscopic intratumoral chemotherapy of lung cancer
- (2008) Firuz Celikoglu et al. LUNG CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now